Health Economics and Decision Science (HEDS), School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.
Eye (Lond). 2011 Apr;25(4):403-13. doi: 10.1038/eye.2011.4. Epub 2011 Jan 28.
Amblyopia is a common condition, which can affect up to 5% of the general population. Health-related quality-of-life (HRQoL) implications of amblyopia and/or its treatment have been explored in the literature. A systematic literature search was undertaken during the period of 7-14 May 2010 to identify the HRQoL implications of amblyopia and/or its treatment. A total of 35 papers were included in the literature review. The HRQoL implications of amblyopia related specifically to amblyopia treatment, rather than to the condition itself. These included impact on family life, social interactions, difficulties in undertaking daily activities, as well as feelings and behaviour. The identified studies adopted a number of methodologies. The study populations included children with the condition, parents of children with amblyopia, and adults who had undertaken amblyopia treatment as a child. Some studies developed their own measures of HRQoL, and others determined HRQoL through proxy measures. The reported findings of the HRQoL implications are of importance when considering the management of cases of amblyopia. The issues identified in the literature review are discussed with respect to how HRQoL is measured (treatment compliance vs proxy measures), and whether HRQoL is taken from a child's or a parent's perspective. Changing societal views over glasses and occlusion therapy are also discussed. Further research is required to assess the immediate and long-term effects of amblyopia and/or its treatment on HRQoL using a more standardised approach.
弱视是一种常见的病症,可能影响高达 5%的普通人群。弱视及其治疗的健康相关生活质量(HRQoL)影响在文献中已经得到了探讨。在 2010 年 5 月 7 日至 14 日期间进行了系统的文献检索,以确定弱视及其治疗的 HRQoL 影响。共有 35 篇论文被纳入文献综述。这些论文中涉及到的弱视的 HRQoL 影响与弱视治疗有关,而不是与弱视本身有关。这些影响包括对家庭生活、社交互动、日常生活活动的困难,以及感觉和行为的影响。确定的研究采用了多种方法。研究人群包括患有这种疾病的儿童、患有弱视的儿童的父母,以及曾经接受过弱视治疗的成年人。一些研究制定了自己的 HRQoL 衡量标准,而另一些则通过代理措施来确定 HRQoL。在考虑弱视病例的管理时,这些被识别的 HRQoL 影响的发现结果非常重要。文献综述中讨论了一些问题,例如如何衡量 HRQoL(治疗依从性与代理措施),以及 HRQoL 是从孩子还是家长的角度来衡量的。还讨论了社会对眼镜和遮盖治疗的看法的变化。需要进一步的研究来评估弱视及其治疗对 HRQoL 的即时和长期影响,采用更标准化的方法。